Skip to main content
# Title Department Research Year
301 Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV Department of Pharmaceutical Organic Chemistry 2021
302 Performance of simvastatin microsponges as a local treatment for chronic periodontitis – Randomized clinical trial Department of Pharmaceutics 2021
303 Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents 2021
304 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
305 Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors Department of Pharmaceutical Organic Chemistry 2021
306 GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the Lungs Department of Pharmaceutics 2021
307 Inversion Kinetics of Some E/Z 3-(Benzylidene)-2-Oxo-indoline Derivatives and Their In Silico CDK2 Docking Studies Department of Medicinal Chemistry 2021
308 Antibiofilm and antivirulence potential of silver nanoparticles against multidrug‐resistant Acinetobacter baumannii Department of Pharmaceutics 2021
309 Cytosolic aromatic dehydrogenase provides benzoic acid for xanthone biosynthesis in Hypericum Department of Pharmacognosy 2021
310 Untargeted Metabolomics Studies on Drug-Incubated Phragmites australis Profiles Department of Pharmacognosy 2021